# XOPENEX HFA

NDC: 27437-056
Generic name: levalbuterol tartrate
Labeler / Manufacturer: Lupin Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: AEROSOL, METERED
Routes: ORAL
Marketing started: 20231110

FDA application: NDA021730

## Active ingredients

- LEVALBUTEROL TARTRATE: 45 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27437-056"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27437-056
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70a35706-d7a8-4a48-98c6-1cab1c42fe8d